[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
$gmab
Genmab's Epcoritamab shows promising results in treating Richter transformation and follicular lymphoma, with new data presented at ASH and FDA approval for a combination therapy. The company is also advancing Acasunlimab trials for NSCLC, with OS data expected by year-end.
About $gmab
Genmab A/S is a Danish biotechnology company focused on developing antibody-based therapies for cancer and other serious diseases.
Insights
- $gmab engagements is up XXXXX% from the previous week.
Engagements: XXXXX (24h)
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XXXXX
X Week: XXXXXX +27%
X Month: XXXXXXX -XX%
X Months: XXXXXXXXX +50%
X Year: XXXXXXXXX +20%
1-Year High: XXXXXXX on 2025-09-29
1-Year Low: XXX on 2025-09-26
Engagements by network (24h): X: XXXXX
Mentions: XX (24h)
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
X Week: XXX -XX%
X Month: XXX -XX%
X Months: XXXXX +171%
X Year: XXXXX +183%
1-Year High: XXX on 2025-11-08
1-Year Low: XX on 2025-01-26
Mentions by network (24h): X: XXX
Creators: XX (24h)
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning $gmab in the last XX hours which is down XX% from XX in the previous XX hours
Daily Average: XX
X Week: XX -XX%
X Month: XXX -XX%
X Months: XXXXX +412%
X Year: XXXXX +344%
1-Year High: XXX on 2025-11-08
1-Year Low: XX on 2025-01-26
The most influential creators that mention $gmab in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @AponiaAnalytics | X | XXXXX | X | XXX |
| @EgidiusLambrech | X | XXX | X | XXX |
| @OzmosiHealth | X | XXXXX | X | XXX |
| @investseekers | X | XXXXX | X | XX |
| @ChonkStocks | X | XXX | X | XX |
| @JohanKirik | X | XXX | X | XX |
| @grok | X | XXXXXXXXX | X | XX |
| @MarcJacksonLA | X | XXXXX | X | XX |
| @Biotwit1 | X | XXX | X | X |
Sentiment: XXX%
Sentiment 24-Hour Time-Series Raw Data
Current Value: XXX%
Daily Average: XX%
X Week: XXX% no change
X Month: XXX% +22%
X Months: XXX% +11%
X Year: XXX% +20%
1-Year High: XXX% on 2025-04-19
1-Year Low: XX% on 2025-01-27
Most Supportive Themes:
- Project Development: (30%) Updates and insights into the ongoing development of the project.
- Partnerships & Collaborations: (15%) News and announcements regarding new partnerships and collaborations.
- Community Building: (45%) Discussions around fostering a strong and engaged community.
Most Critical Themes:
- Market Volatility: (7.5%) Concerns and discussions regarding the fluctuating market price.
- Regulatory Uncertainty: (2.5%) Anxiety surrounding potential regulatory changes and their impact.
Top $gmab Social Posts
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"#Epcoritamab kan blive en gamechanger i behandlingen af #Richters transformation $GMAB $ABBV @Genmab #AbbVie #Epkinly"
X Link @EgidiusLambrech 2025-12-10T09:45Z XXX followers, XXX engagements
"#Epcoritamab offers new hope for patients with #Richter Transformation - one of the most aggressive and difficult-to-treat forms of lymphoma. $GMAB $ABBV @Genmab #AbbVie #Epkinly @amsterdamumc"
X Link @EgidiusLambrech 2025-12-10T09:18Z XXX followers, XXX engagements
"$GMAB Genmab presented P1 Chronic Lymphoid Leukemia results on 2025-12-08 for Epcoritamab More Info:"
X Link @OzmosiHealth 2025-12-09T21:21Z 3016 followers, XXX engagements
"$GMAB kissing the XX ema today. Increased my position. Low risk they have collaborations with multiple heavy weights. They are creating anti-body cancer solutions like the fun"
X Link @JohanKirik 2025-12-09T17:08Z XXX followers, XX engagements